2021年亚太过敏、哮喘和临床免疫学协会国际会议

APAAACI 2021 International Conference Joint TAAACI will be held on 15-17 October, 2021, in Kaohsiung, Taiwan. With an outstanding scientific program, well-woven combination of the recent advances and practical clinical and key experts from the region and around the world, the conference will provide the latest advances in clinical, research, hands-on and problem-based learning. Do NOT miss out on this wonderful opportunity. 

General Policy

• All abstracts must be submitted and be received on or before June 30, 2021 through Online Abstract Submission System.
• All abstracts will be reviewed by the Scientific Program Committee of the APAAACI 2021 International Conference Joint TAAACI and reviewing results will be announced by emailing a notice of acceptance / rejection to presenting authors only by (TBD).
• The author submitting the abstract MUST provide one presenting author and one corresponding author. The presenting author of an accepted abstract (oral and poster) must register and pay the registration fees before Deadline for Early Bird Registration July 30, 2021 to ensure the rights for the presentation.
• Abstracts must be original and have not been published or presented at any conference prior to the APAAACI 2021 International Conference Joint TAAACI. The accepted abstracts will be published in the Abstract Book.
• Accepted abstracts will be presented in either Poster Sessions or Oral Sessions presented between 15–17 October 2021.
• Presenting Authors of accepted abstracts MUST be registered delegates even if they are a student and be responsible for all expenses incurred in the production of their presentations, travel and accommodation during the Conference. Each Presenting Author can submit only one abstract but can be a co-author of another abstract.
• It is the author’s responsibility to submit a correctly edited and accurate abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author. Abstracts will be rejected if they contain no data or if the English is unacceptable. All Presenting Authors will receive, closer to the Congress, detailed presentation guidelines when their abstract/s has/have been accepted.
• Acknowledgement of the receipt of abstract submission will be sent to the Presenting Author’s email address immediately upon submission. The Presenting Author will receive all correspondence regarding the abstract status, presentation type, date and time, via the email that is provided in the abstract submission.
• Authors can indicate their choice of preferred type of presentation in our submission system.

Submission Guidelines

1. a. Identifying information such as author or institution names should not be included in the title.
2. b. Each word should begin with a Capital Letter except for transition words.
3. c. NO full stop (or period) at the end and NO underlining.

1. a. A maximum of 300 words is allowed.
2. b. Tables and graphs should not be included.
3. c. References (maximum of 2) can be included in the body of the text.
4. d. Structure must consist of the following components.
   • Background: A statement of purpose of the study (preferably one sentence).
   • Methods: An explanation of the study design and experimental methods used.
   • Results: A concise summary of the major findings of the experiment or study. Sufficient data must be provided to permit evaluation by the reviewers and public reading the abstracts. Statements such as "the data will be discussed" are not acceptable.
   • Conclusion(s): Summary of the overall findings and the importance of the study.

Abstract Topics

1. Immunotherapy
2. Food Allergy
3. Basic Science
   1. a: Mucosal Immunology
   2. b: Microbiota
   3. c: Immune Regulation
4. Technology
   1. a: AI / Database Analysis
   2. b: Single Cell Technology
5. Environmental Allergy/Immunology
6. Eosinophils and Related Diseases
7. Atopic Dermatitis
8. Urticaria
9. Autoimmunity
10. Advances in treatment
11. Allergy-related Sinonasal Diseases
12. Asthma & Respiratory Allergic Disease
13. Anaphylaxis
14. Drug Hypersensitivity and Desensitization
15. Covid-19
    1. a: Vaccination
    2. b: Therapy
    3. c: Immune Response
16. Inflammatory Diseases
17. Immunodeficiency
18. Tumor Immunology
19. Others

Award Application

• Submit an abstract and be the presenting author of the abstract.
• Complete the online registration and pay the registration fee in advance.
• The same abstract cannot be submitted for consideration in different award prizes.
• Indicate the application by choosing “Young Investigator Award” or “Travel Award” while submitting online.
• “Young Investigator Award” applicants should be under the age of 40.